HIGHLIGHTS
- who: Kwangmin Kim and collaborators from the Department of Surgery, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea have published the article: Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19-Induced ARDS Patients: A Case Report, in the Journal: Medicina 2022, 58, 1698. of /2022/
- what: Purpose: This study assessed the safety feasibility and tolerability of mesenchymal stem cells for patients diagnosed with COVID (Coronavirus disease 2019-induced ARDS (acute respiratory distress syndrome)). The main outcome of this study was to assess the safety adverse events and efficacy following transplantation of hBMSCs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.